Correction to: Scientific Reports https://doi.org/10.1038/s41598-021-90219-1, published online 27 May 2021
The original version of this Article contained errors.
In Figure 5 the labels at the top and bottom of the figure were incorrectly captured. The original Figure 5 and accompanying legend appear below.
High-content confocal microscopy autophagy analysis. (a) Left panel illustrates the principle of high content confocal microscopy analysis. Briefly, 1 × 104 pCMV-RFPLC3GFP transfected cells were treated with doxorubicin (500 nM—24 h) and Carmofur (10 µM—24 h). After treatments, cells were fixed and analyzed for GFP + RFP + overlapping puncta and for GFP − /RFP + vesicle content. Around 103 transfected cells/well were analyzed using Harmony algorithms, where RFP + /GFP + vesicles are counted as autophagosomes and RFP + /GFP − vesicles are counted as autolysosomes. The outcome of this test is the following: an autophagy inducer will increase RFP + /GFP + and RFP + /GFP − vesicles, an autophagy blocker will increase RFP + /GFP + but decrease RFP + /GFP − vesicles, whereas an autophagy inhibitor will decrease RFP + /GFP + and RFP + /GFP − vesicles. Right panel shows an overview of a single High-Content acquisition, in which every big square comprises hundreds of 3% overlapping images taken at × 63 magnification. (b) Images taken from the acquisition shown in (a). (c,d) Statistical analysis of RFP + /GFP + and RFP + /GFP − vesicles revealed that A375 cells increases the RFP + /GFP + and RFP + /GFP − vesicles when exposed to doxorubicin, compared to A375 AC-null cells, in which autophagy inhibition was detected. Statistical analyses were performed using one-way ANOVA test (*p < 0.05, **p < 0.01, ***p < 0.001). Data are expressed as mean ± SD.
In addition, the Author Contributions section was incomplete.
“Conceptualization, M.L. and R.A.; methodology, V.L.R.; validation and statistical analysis, R.A; lipidomic assays M.B; revision of manuscript, G.F., D.P. and MP; writing—original draft preparation, V.L.R; writing review and editing, M.L., R.A.; Confocal screenings: M.L., P.S. All authors have read and agreed to the published version of the manuscript.”
now reads:
“Conceptualization, M.L. and R.A.; methodology, V.L.R.; validation and statistical analysis, R.A; lipidomic assays M.B; data curation, funds management PQ; revision of manuscript, G.F., D.P. and MP; writing—original draft preparation, V.L.R; writing review and editing, M.L., R.A.; Confocal screenings: ML, P.S. All authors have read and agreed to the published version of the manuscript.”
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lai, M., Amato, R., La Rocca, V. et al. Publisher Correction: Acid ceramidase controls apoptosis and increases autophagy in human melanoma cells treated with doxorubicin. Sci Rep 11, 20330 (2021). https://doi.org/10.1038/s41598-021-99797-6
Published:
DOI: https://doi.org/10.1038/s41598-021-99797-6
This article is cited by
-
Lipid rafts: novel therapeutic targets for metabolic, neurodegenerative, oncological, and cardiovascular diseases
Lipids in Health and Disease (2025)